What is Tirzepatide?
A plain-English guide to dual GLP-1 / GIP treatment for weight management.
The simple version
Tirzepatide is a once-weekly injectable medication that activates two hormone pathways involved in appetite, fullness, and blood sugar regulation: GLP-1 and GIP.
It is the active ingredient in brand-name medications such as Mounjaro® and Zepbound®.
How it may help
Tirzepatide may help support:
- Appetite regulation
- Reduced food noise
- Longer-lasting fullness
- Weight management
- Metabolic health
Why people choose it
Tirzepatide is often chosen by people looking for a stronger average weight-loss profile compared with earlier GLP-1 options.
In clinical studies of FDA-approved tirzepatide for chronic weight management, participants taking the highest dose lost substantial body weight over 72 weeks.
How treatment works
- Complete a brief online intake
- A licensed clinician reviews your eligibility
- If prescribed, medication is shipped to your door
- Your care team helps guide adjustments over time
Important safety note
Tirzepatide is not appropriate for everyone. A licensed clinician should review your medical history, current medications, and weight-management goals before treatment.
Ready to take the next step?
Complete your intake in minutes. A licensed clinician reviews your plan.
See if you're eligible →Compounded medications are prepared per prescription and are not FDA-approved as drugs. Individual results vary.